Tag: antisense therapy

Medical illustration showing hepatitis B virus suppression with new antisense oligonucleotide therapy
New StudiesResearch Digest

Experimental Drug Shows 96% Viral Suppression in Hepatitis B Clinical Trial

Clinical trial shows experimental drug bepirovirsen achieves 96% viral suppression when combined with standard hepatitis B therapy. Phase III trials…

By
GMJ Research Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network